Comparative effect of ozone exposure and 5-aminosalicylic acid in oxazolon-induced colitis upon the indices of innate immunity
- Authors: Osikov M.V.1,2, Kaigorodtseva N.V.1,2, Boyko M.S.1, Fedosov A.A.3,4
-
Affiliations:
- South Ural State Medical University
- Chelyabinsk Regional Clinical Hospital
- N. Pirogov Russian National Research Medical University
- Peoples’ Friendship University of Russia
- Issue: Vol 25, No 3 (2022)
- Pages: 259-266
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/120188
- DOI: https://doi.org/10.46235/1028-7221-1152-CEO
- ID: 120188
Cite item
Full Text
Abstract
Multiple effects of ozone are a prerequisite for its use in the complex therapy of inflammatory bowel diseases. Our aim was to analyze the effects of ozone and 5-aminosalicylic acid (5-ASA) in oxazolone-induced colitis (OIC) upon the innate immunity functions.
OIC was modeled in 72 male Wistar rats weighing 240±20 g by a two-stage application of oxazolone solution. Ozone at a dose of 0.05 mg/kg, as a part of ozone-oxygen mixture, was injected intraperitoneally every 24 hours. The laboratory indices were studied on the days 2, 4, 6. In blood samples, the number of leukocytes, differential leukocyte counts, absorptive capacity of blood neutrophils and their oxygen-dependent metabolism were studied. In homogenate of the colon mucosa, IL-17 concentration was measured.
In OIC, on days 2, 4, and 6, the number of blood leukocytes was increased, with a predominance of lymphocytes, monocytes, neutrophils and their absorption capacity; the concentration of IL-17 increased in the areas of colonic damage. On days 2 and 4, the activity and intensity of the spontaneous NBT test is increased like as activity and intensity of induced NBT-test on days 2 and 6. Administration of ozone reduced the content of blood leukocytes, lymphocytes, neutrophils on days 2 and 6, like as their absorption capacity on days 2 and 4, along with a decrease in NCT-reducing ability on days 6, and decreased IL-17 concentration in the area of colonic damage on days 4 and 6. The effects of ozone administration in OIC, if compared with 5-ASA, are less pronounced on days 2 and 4, with respect to decreased number of monocytes, neutrophils in blood and their absorption capacity on days 2, like as IL-17 concentration in the area of colonic damage on days 4 and 6.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. V. Osikov
South Ural State Medical University; Chelyabinsk Regional Clinical Hospital
Author for correspondence.
Email: prof.osikov@yandex.ru
PhD, MD (Medicine), Professor, Head, Department of Pathological Physiology; Head, Research Department
Russian Federation, Chelyabinsk; ChelyabinskN. V. Kaigorodtseva
South Ural State Medical University; Chelyabinsk Regional Clinical Hospital
Email: prof.osikov@yandex.ru
Assistant Professor, Department of Pathological Physiology; Anesthesiologist-Resuscitator, Resuscitation and Intensive Care Unit No. 3
Russian Federation, Chelyabinsk; ChelyabinskM. S. Boyko
South Ural State Medical University
Email: prof.osikov@yandex.ru
Assistant Professor, Department of Pathological Physiology
Russian Federation, ChelyabinskA. A. Fedosov
N. Pirogov Russian National Research Medical University; Peoples’ Friendship University of Russia
Email: prof.osikov@yandex.ru
PhD (Medicine), Associate Professor, Department of Anatomy, Faculty of Medicine; Associate Professor, Department of Histology, Cytology and Embryology
Russian Federation, Moscow; MoscowReferences
- Осиков М.В., Симонян Е.В., Бакеева А.Е., Огнева О.И. Иммунотропные эффекты куркумина в составе оригинальных ректальных суппозиториев при экспериментальной болезни Крона // Медицинская иммунология, 2020. Т. 22, № 3. С. 483-496. [Osikov M.V., Simonyan E.V., Bakeeva A.E., Ogneva O.I. Immunotropic effects of curcumin in the composition of original rectal suppositories in experimental Crohn’s disease. Meditsinskaya immunologiya = Medical Immunology (Russia), 2020, Vol. 22, no. 3. pp. 483-496. (In Russ.)] doi: 10.15789/1563-0625-IEO-1875.
- Осиков М.В., Симонян Е.В., Бакеева А.Е., Астахова Л.В. Морфологические аспекты протекторного действия оригинальных ректальных суппозиториев с экстрактом куркумы при экспериментальной болезни Крона // Патологическая физиология и экспериментальная терапия, 2021. Т. 65, № 2. С. 67-77. [Osikov M.V., Simonyan E.V., Bakeeva A.E., Astakhova L.V. Morphological aspects of the protective effect of the original rectal suppositories with turmeric extract in experimental Crohn’s disease. Patologicheskaya fiziologiya i eksperimentalnaya terapiya = Pathological Physiology and Experimental Therapy, 2021, Vol. 65, no. 2, pp. 67-77. (In Russ.)]
- Осиков М.В., Бойко М.С., Симонян Е.В., Ушакова В.А. Иммунотропные эффекты витамина D3 в составе оригинальных ректальных суппозиториев при экспериментальном язвенном колите / М.В. Осиков, // Медицинская иммунология, 2021. Т. 23, № 3. С. 497-508. [Osikov M.V., Boyko M.S., Simonyan E.V., Ushakova V.A. Immunotropic effects of vitamin D3 in the composition of original rectal suppositories in experimental ulcerative colitis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2021, Vol. 23, no. 3, pp. 497-508. (In Russ.)] doi: 10.15789/1563-0625-IEO-2176.
- Пат. 2740060 РФ. Лекарственная форма для лечения и профилактики язвенного колита, содержащая пэгилированную липосомальную форму эритропоэтина в форме суппозиториев, обладающая противовоспалительными и иммуномодулирующим действием / М.В. Осиков, Е.В. Симонян, И.Р. Галеева. Прим. 14.02.2020. [Pat. 2740060 RF. A dosage form for the treatment and prevention of ulcerative colitis containing a pegylated liposomal form of erythropoietin in the form of suppositories with anti-inflammatory and immunomodulatory effects / M.V. Osikov, E.V. Simonyan, I.R. Galeeva. Approx. 14.02.2020].
- Fitzpatrick E., Holland O.J., Vanderlelie J.J. Ozone therapy for the treatment of chronic wounds: A systematic review. Int. Wound J., 2018, Vol. 15, no. 4, pp. 633-644.
- Kiesler P., Fuss I.J., Strober W. Experimental models of inflammatory bowel diseases. Cell. Mol. Gastroenterol. Hepatol., 2015. Vol. 1, no. 2, pp. 154-170.
- Manoto S.L., Maepa M.J., Motaung S.K. Medical ozone therapy as a potential treatment modality for regeneration of damaged articular cartilage in osteoarthritis. Saudi J. Biol. Sci., 2018, Vol. 25, no. 4, pp. 672-679.
- Na Y.R., Stakenborg M., Seok S.H., Matteoli G. Macrophages in intestinal inflammation andresolution: a potential therapeutic target in IBD. Nat. Rev. Gastroenterol. Hepatol., 2019, Vol. 16, no. 9, pp. 531-543.
- Osikov M.V., Boyko M.S., Fedosov A.A., Ilyinykh M.A. Effectiveness of experimental colitis therapy with original vitamin D3 rectal suppositories. Int. J. Biomed., 2022, Vol 12, no. 1, pp. 124-133.
- Swanson K.V., Deng M., Ting J.P.Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol., 2019, Vol. 19, no. 8, pp. 477-489.
- Weisshof R., El Jurdi K., Zmeter N., Rubin D.T. Emerging therapies for inflammatory bowel disease. Adv. Ther., 2018, Vol. 35, no. 11, pp. 1746-1762.
- Wang Z., Zhang A., Meng W., Wang T., Li D., Liu Z., Liu H. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol., 2018, Vol. 835, pp. 82-93.
- Yu G., Bai Z., Chen Z., Chen H., Wang G., Wang G., Liu Z. The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease. Int. Immunopharmacol., 2017, Vol. 43, pp. 203-209.
Supplementary files
